A novel approach to non-invasive glucose measurement by mid-infrared spectroscopy: The combination of quantum cascade lasers (QCL) and photoacoustic detection

True non-invasive glucose measurement procedures are presently not available to the diabetic patient. There have been many different approaches without useful results. Here, we present a new concept to measure glucose non-invasively based on mid-infrared spectroscopy (MIR) which overcomes the difficulties of other methods. Basically it consists of the combination of QCL derived radiation and photoacoustic detection of absorption. Theoretical considerations and first in vivo results show that this approach will lead to a true non-invasive specific glucose measurement.

[1]  C. Malchoff,et al.  A novel noninvasive blood glucose monitor. , 2002, Diabetes care.

[2]  D. Accili,et al.  Glucose effects on skin keratinocytes: implications for diabetes skin complications. , 2001, Diabetes.

[3]  R. Esenaliev,et al.  Noninvasive blood glucose monitoring with optical coherence tomography: a pilot study in human subjects. , 2002, Diabetes care.

[4]  G. W. Small,et al.  Comparison of combination and first overtone spectral regions for near-infrared calibration models for glucose and other biomolecules in aqueous solutions. , 2004, Analytical chemistry.

[5]  R. Cancedda,et al.  “HepG2/erythroid/brain” type glucose transporter (GLUT1) is highly expressed in human epidermis: Keratinocyte differentiation affects glut1 levels in reconstituted epidermis , 1992, Journal of cellular physiology.

[6]  D. Accili,et al.  The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. , 2001, Endocrinology.

[7]  N. Bendsøe,et al.  Human epidermal energy metabolism is functionally anaerobic , 2003, Experimental dermatology.

[8]  Peter Elsner,et al.  Skin Bioengineering: Techniques and Applications in Dermatology and Cosmetology , 1998 .

[9]  I. Gabriely,et al.  Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. , 1999, Diabetes care.

[10]  G. Dailey.  Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review , 2004, Current medical research and opinion.

[11]  A Caduff,et al.  First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. , 2003, Biosensors & bioelectronics.

[12]  L. Goldsmith.  Current problems in dermatology , 1988 .

[13]  T. B. Blank,et al.  Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy. , 1999, Clinical chemistry.

[14]  Peter C O'Brien,et al.  Dermal Interstitial Glucose as an Indicator of Ambient Glycemia , 1997, Diabetes Care.